

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | positive T cell selection (GO:0043368) | 8.72761914 |
| 2 | regulation of gamma-delta T cell differentiation (GO:0045586) | 8.70677451 |
| 3 | negative T cell selection (GO:0043383) | 8.63059013 |
| 4 | positive regulation of gamma-delta T cell activation (GO:0046645) | 8.36888676 |
| 5 | regulation of gamma-delta T cell activation (GO:0046643) | 7.79944600 |
| 6 | T cell selection (GO:0045058) | 7.57954079 |
| 7 | negative regulation of thymocyte apoptotic process (GO:0070244) | 7.48819153 |
| 8 | * V(D)J recombination (GO:0033151) | 7.35397478 |
| 9 | activated T cell proliferation (GO:0050798) | 7.20589739 |
| 10 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 7.05965357 |
| 11 | negative thymic T cell selection (GO:0045060) | 6.76345184 |
| 12 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 6.72993557 |
| 13 | positive thymic T cell selection (GO:0045059) | 6.51418248 |
| 14 | T cell receptor signaling pathway (GO:0050852) | 6.29538724 |
| 15 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 6.16749585 |
| 16 | negative regulation of cell killing (GO:0031342) | 6.16749585 |
| 17 | interferon-gamma production (GO:0032609) | 6.11686760 |
| 18 | thymic T cell selection (GO:0045061) | 6.09687959 |
| 19 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 5.90850588 |
| 20 | T cell costimulation (GO:0031295) | 5.11044833 |
| 21 | positive regulation of interleukin-2 production (GO:0032743) | 5.01361960 |
| 22 | lymphocyte costimulation (GO:0031294) | 5.01249009 |
| 23 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 5.00215250 |
| 24 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 5.00215250 |
| 25 | antigen receptor-mediated signaling pathway (GO:0050851) | 4.91234095 |
| 26 | response to interleukin-15 (GO:0070672) | 4.89206805 |
| 27 | regulation of thymocyte apoptotic process (GO:0070243) | 4.88440516 |
| 28 | regulation of interleukin-2 biosynthetic process (GO:0045076) | 4.87762943 |
| 29 | * T cell differentiation (GO:0030217) | 4.68649294 |
| 30 | regulation of T cell tolerance induction (GO:0002664) | 4.60753625 |
| 31 | mucosal-associated lymphoid tissue development (GO:0048537) | 4.45541338 |
| 32 | Peyers patch development (GO:0048541) | 4.45541338 |
| 33 | regulation of T cell receptor signaling pathway (GO:0050856) | 4.41109816 |
| 34 | * alpha-beta T cell differentiation (GO:0046632) | 4.26203815 |
| 35 | negative regulation of lymphocyte mediated immunity (GO:0002707) | 4.25310827 |
| 36 | regulation of isotype switching to IgG isotypes (GO:0048302) | 4.21014027 |
| 37 | * alpha-beta T cell activation (GO:0046631) | 4.15392466 |
| 38 | cellular response to interleukin-15 (GO:0071350) | 4.15088908 |
| 39 | negative regulation of T cell apoptotic process (GO:0070233) | 4.13050849 |
| 40 | antigen processing and presentation of endogenous antigen (GO:0019883) | 4.09839246 |
| 41 | regulation of antigen receptor-mediated signaling pathway (GO:0050854) | 4.00925643 |
| 42 | mast cell activation (GO:0045576) | 3.90687090 |
| 43 | modulation by virus of host process (GO:0019054) | 3.87722605 |
| 44 | regulation of regulatory T cell differentiation (GO:0045589) | 3.87347448 |
| 45 | regulation of defense response to virus by virus (GO:0050690) | 3.86578867 |
| 46 | T cell homeostasis (GO:0043029) | 3.83339193 |
| 47 | regulation of granulocyte differentiation (GO:0030852) | 3.83173845 |
| 48 | positive regulation of calcium-mediated signaling (GO:0050850) | 3.82169163 |
| 49 | positive regulation of tolerance induction (GO:0002645) | 3.79083322 |
| 50 | regulation of interleukin-2 production (GO:0032663) | 3.76777784 |
| 51 | * somatic diversification of immune receptors via germline recombination within a single locus (GO:000 | 3.73687815 |
| 52 | * somatic cell DNA recombination (GO:0016444) | 3.73687815 |
| 53 | T cell differentiation in thymus (GO:0033077) | 3.73191265 |
| 54 | leukocyte aggregation (GO:0070486) | 3.72753628 |
| 55 | B cell receptor signaling pathway (GO:0050853) | 3.70370149 |
| 56 | positive regulation of type I interferon-mediated signaling pathway (GO:0060340) | 3.68500375 |
| 57 | negative regulation of leukocyte mediated immunity (GO:0002704) | 3.65344773 |
| 58 | * T cell activation (GO:0042110) | 3.62862470 |
| 59 | mast cell activation involved in immune response (GO:0002279) | 3.56378159 |
| 60 | mast cell degranulation (GO:0043303) | 3.56378159 |
| 61 | negative regulation of erythrocyte differentiation (GO:0045647) | 3.54572259 |
| 62 | T cell migration (GO:0072678) | 3.51764592 |
| 63 | positive regulation of T cell differentiation in thymus (GO:0033089) | 3.48924290 |
| 64 | response to muramyl dipeptide (GO:0032495) | 3.47250342 |
| 65 | modulation by symbiont of host cellular process (GO:0044068) | 3.46093683 |
| 66 | * somatic diversification of immune receptors (GO:0002200) | 3.40791218 |
| 67 | CD4-positive, alpha-beta T cell differentiation (GO:0043367) | 3.39332191 |
| 68 | regulation of T cell mediated cytotoxicity (GO:0001914) | 3.37898212 |
| 69 | immune response-activating cell surface receptor signaling pathway (GO:0002429) | 3.33288759 |
| 70 | regulation of alpha-beta T cell proliferation (GO:0046640) | 3.28740469 |
| 71 | regulation of alpha-beta T cell activation (GO:0046634) | 3.27475986 |
| 72 | detection of bacterium (GO:0016045) | 3.26421003 |
| 73 | positive regulation of granulocyte differentiation (GO:0030854) | 3.26075490 |
| 74 | regulation of tolerance induction (GO:0002643) | 3.21735684 |
| 75 | positive regulation by symbiont of host defense response (GO:0052509) | 3.21208702 |
| 76 | modulation by symbiont of host defense response (GO:0052031) | 3.21208702 |
| 77 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 3.21208702 |
| 78 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 3.21208702 |
| 79 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 3.21208702 |
| 80 | modulation by symbiont of host immune response (GO:0052553) | 3.21208702 |
| 81 | lymphocyte homeostasis (GO:0002260) | 3.21142974 |
| 82 | positive regulation of B cell differentiation (GO:0045579) | 3.18816812 |
| 83 | negative regulation of T cell receptor signaling pathway (GO:0050860) | 3.17549246 |
| 84 | lymph node development (GO:0048535) | 3.16539249 |
| 85 | positive regulation of alpha-beta T cell activation (GO:0046635) | 3.15838803 |
| 86 | detection of other organism (GO:0098543) | 3.15703019 |
| 87 | regulation of humoral immune response mediated by circulating immunoglobulin (GO:0002923) | 3.15418564 |
| 88 | positive regulation of alpha-beta T cell proliferation (GO:0046641) | 3.14976107 |
| 89 | negative regulation of adaptive immune response based on somatic recombination of immune receptors b | 3.14961101 |
| 90 | negative regulation of CD4-positive, alpha-beta T cell activation (GO:2000515) | 3.14600553 |
| 91 | T cell proliferation (GO:0042098) | 3.13238052 |
| 92 | histone H3-K36 demethylation (GO:0070544) | 3.12364757 |
| 93 | positive regulation of T cell mediated cytotoxicity (GO:0001916) | 3.11461128 |
| 94 | antigen processing and presentation via MHC class Ib (GO:0002475) | 3.11438061 |
| 95 | regulation of natural killer cell mediated immunity (GO:0002715) | 3.09524645 |
| 96 | regulation of natural killer cell mediated cytotoxicity (GO:0042269) | 3.09524645 |
| 97 | regulation of leukocyte mediated cytotoxicity (GO:0001910) | 3.08531805 |
| 98 | natural killer cell differentiation (GO:0001779) | 3.07703734 |
| 99 | positive regulation of natural killer cell mediated cytotoxicity (GO:0045954) | 3.07507904 |
| 100 | positive regulation of natural killer cell mediated immunity (GO:0002717) | 3.07507904 |
| 101 | CD4-positive, alpha-beta T cell activation (GO:0035710) | 3.06373653 |
| 102 | negative regulation of lymphocyte apoptotic process (GO:0070229) | 3.05794866 |
| 103 | * lymphocyte differentiation (GO:0030098) | 3.05567157 |
| 104 | regulation of interleukin-4 production (GO:0032673) | 3.03381785 |
| 105 | positive regulation of T cell activation (GO:0050870) | 3.01891014 |
| 106 | negative regulation of glycoprotein biosynthetic process (GO:0010561) | 3.01519628 |
| 107 | tolerance induction (GO:0002507) | 3.01041933 |
| 108 | cellular extravasation (GO:0045123) | 3.00949908 |
| 109 | regulation of interferon-gamma-mediated signaling pathway (GO:0060334) | 3.00185686 |
| 110 | cellular hyperosmotic response (GO:0071474) | 2.99841939 |
| 111 | positive regulation of alpha-beta T cell differentiation (GO:0046638) | 2.99247404 |
| 112 | regulation of response to interferon-gamma (GO:0060330) | 2.98033821 |
| 113 | CD4-positive, alpha-beta T cell differentiation involved in immune response (GO:0002294) | 2.97643985 |
| 114 | T-helper cell differentiation (GO:0042093) | 2.97643985 |
| 115 | regulation of B cell receptor signaling pathway (GO:0050855) | 2.97107941 |
| 116 | positive regulation of histone deacetylation (GO:0031065) | 2.97056329 |
| 117 | regulation of T cell differentiation (GO:0045580) | 2.94748265 |
| 118 | regulation of interleukin-12 biosynthetic process (GO:0045075) | 2.94257152 |
| 119 | regulation of alpha-beta T cell differentiation (GO:0046637) | 2.94181652 |
| 120 | positive regulation of isotype switching (GO:0045830) | 2.92205832 |
| 121 | positive regulation of leukocyte mediated cytotoxicity (GO:0001912) | 2.90804302 |
| 122 | positive regulation of T cell differentiation (GO:0045582) | 2.89855264 |
| 123 | negative regulation of innate immune response (GO:0045824) | 2.88294089 |
| 124 | negative regulation of phagocytosis (GO:0050765) | 2.87206818 |
| 125 | regulation of cell killing (GO:0031341) | 2.86760462 |
| 126 | T cell lineage commitment (GO:0002360) | 2.84969150 |
| 127 | histone monoubiquitination (GO:0010390) | 2.81838131 |
| 128 | regulation of T cell activation (GO:0050863) | 2.78926316 |
| 129 | negative regulation of T cell mediated immunity (GO:0002710) | 2.77433042 |
| 130 | regulation of T cell apoptotic process (GO:0070232) | 2.75934851 |
| 131 | regulation of B cell differentiation (GO:0045577) | 2.74874003 |
| 132 | negative regulation of antigen receptor-mediated signaling pathway (GO:0050858) | 2.74711821 |
| 133 | T cell differentiation involved in immune response (GO:0002292) | 2.74121169 |
| 134 | alpha-beta T cell differentiation involved in immune response (GO:0002293) | 2.74121169 |
| 135 | alpha-beta T cell activation involved in immune response (GO:0002287) | 2.74121169 |
| 136 | signal complex assembly (GO:0007172) | 2.71495350 |
| 137 | DNA unwinding involved in DNA replication (GO:0006268) | 2.70530112 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 7.19889912 |
| 2 | E2F7_22180533_ChIP-Seq_HELA_Human | 6.59838215 |
| 3 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 5.47279993 |
| 4 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 4.66340846 |
| 5 | MYC_22102868_ChIP-Seq_BL_Human | 4.53887544 |
| 6 | * FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 3.51079442 |
| 7 | * RUNX_20019798_ChIP-Seq_JUKART_Human | 3.33434311 |
| 8 | MYB_26560356_Chip-Seq_TH2_Human | 3.29554440 |
| 9 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 3.07399640 |
| 10 | * UTX_26944678_Chip-Seq_JUKART_Human | 2.93819959 |
| 11 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 2.92944668 |
| 12 | * STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 2.89685239 |
| 13 | MAF_26560356_Chip-Seq_TH1_Human | 2.82810119 |
| 14 | VDR_21846776_ChIP-Seq_THP-1_Human | 2.62007649 |
| 15 | MYB_26560356_Chip-Seq_TH1_Human | 2.56227053 |
| 16 | * KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 2.48126064 |
| 17 | * TCF7_22412390_ChIP-Seq_EML_Mouse | 2.45552709 |
| 18 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 2.33983844 |
| 19 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 2.31846399 |
| 20 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 2.20963885 |
| 21 | KDM2B_26808549_Chip-Seq_DND41_Human | 2.19758302 |
| 22 | * GATA3_27048872_Chip-Seq_THYMUS_Human | 2.16119634 |
| 23 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 2.11639443 |
| 24 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 2.09590006 |
| 25 | E2F4_17652178_ChIP-ChIP_JURKAT_Human | 2.07378268 |
| 26 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 2.04788602 |
| 27 | CIITA_25753668_ChIP-Seq_RAJI_Human | 1.99990165 |
| 28 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.98275302 |
| 29 | MAF_26560356_Chip-Seq_TH2_Human | 1.94072759 |
| 30 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.85252435 |
| 31 | * E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.77495480 |
| 32 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.76124986 |
| 33 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.75013847 |
| 34 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.71979906 |
| 35 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.71719881 |
| 36 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.70495498 |
| 37 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.53798357 |
| 38 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 1.51768699 |
| 39 | FOXM1_25889361_ChIP-Seq_OE33_AND_U2OS_Human | 1.51273344 |
| 40 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 1.42866504 |
| 41 | RUNX1_17652178_ChIP-ChIP_JURKAT_Human | 1.42239195 |
| 42 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 1.40847414 |
| 43 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 1.39398905 |
| 44 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 1.37884793 |
| 45 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.37407763 |
| 46 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 1.34809908 |
| 47 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.34271359 |
| 48 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.33985115 |
| 49 | SPI1_23547873_ChIP-Seq_NB4_Human | 1.33140830 |
| 50 | * MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.32958922 |
| 51 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.31003998 |
| 52 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.30711944 |
| 53 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.29165344 |
| 54 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.26587418 |
| 55 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 1.22943710 |
| 56 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.21505095 |
| 57 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 1.20551753 |
| 58 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.14951071 |
| 59 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.14853910 |
| 60 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.14666422 |
| 61 | SPI1_23127762_ChIP-Seq_K562_Human | 1.14221254 |
| 62 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.13474993 |
| 63 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.12373533 |
| 64 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.11220820 |
| 65 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.10645049 |
| 66 | FOXP3_21729870_ChIP-Seq_TREG_Human | 1.10360129 |
| 67 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.08432265 |
| 68 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 1.08234031 |
| 69 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.07236185 |
| 70 | VDR_20736230_ChIP-Seq_LYMPHOBLASTOID_Human | 1.05927170 |
| 71 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.05777458 |
| 72 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.05455781 |
| 73 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.04826199 |
| 74 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.03662039 |
| 75 | MYC_19079543_ChIP-ChIP_MESCs_Mouse | 1.03484313 |
| 76 | VDR_23849224_ChIP-Seq_CD4+_Human | 1.03165014 |
| 77 | NCOR1_26117541_ChIP-Seq_K562_Human | 1.01751483 |
| 78 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 0.99891536 |
| 79 | KDM5A_27292631_Chip-Seq_BREAST_Human | 0.99647962 |
| 80 | GFI1B_20887958_ChIP-Seq_HPC-7_Mouse | 0.98894803 |
| 81 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 0.98677064 |
| 82 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.98496646 |
| 83 | E2F1_21310950_ChIP-Seq_MCF-7_Human | 0.97797368 |
| 84 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.96006294 |
| 85 | CREB1_23762244_ChIP-Seq_HIPPOCAMPUS_Rat | 0.95549048 |
| 86 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.94831935 |
| 87 | GATA1_19941826_ChIP-Seq_K562_Human | 0.93401716 |
| 88 | GATA3_26560356_Chip-Seq_TH2_Human | 0.93236066 |
| 89 | XRN2_22483619_ChIP-Seq_HELA_Human | 0.92561456 |
| 90 | TP63_19390658_ChIP-ChIP_HaCaT_Human | 0.91565063 |
| 91 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 0.90247310 |
| 92 | DMRT1_21621532_ChIP-ChIP_FETAL_Ovary | 0.88337898 |
| 93 | GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.87737026 |
| 94 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 0.86957729 |
| 95 | PU_27001747_Chip-Seq_BMDM_Mouse | 0.86956146 |
| 96 | BCL6_27268052_Chip-Seq_Bcells_Human | 0.86057740 |
| 97 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.85011440 |
| 98 | PKCTHETA_26484144_Chip-Seq_BREAST_Human | 0.84988988 |
| 99 | BCOR_27268052_Chip-Seq_Bcells_Human | 0.84824568 |
| 100 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.82915746 |
| 101 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 0.82117625 |
| 102 | * RUNX1_22897851_ChIP-Seq_JUKARTE6-1_Human | 0.80599730 |
| 103 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 0.80203338 |
| 104 | ERG_20887958_ChIP-Seq_HPC-7_Mouse | 0.80054989 |
| 105 | HOXA2_22223247_ChIP-Seq_E11.5_EMBRYO_Mouse | 0.79859035 |
| 106 | GATA3_26560356_Chip-Seq_TH1_Human | 0.79849198 |
| 107 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 0.79706869 |
| 108 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.79508233 |
| 109 | RUNX1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.79380734 |
| 110 | ELK1_19687146_ChIP-ChIP_HELA_Human | 0.78417832 |
| 111 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 0.77810707 |
| 112 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 0.77781163 |
| 113 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.77679249 |
| 114 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 0.77274367 |
| 115 | CTCF_21964334_ChIP-Seq_BJAB-B_Human | 0.76735920 |
| 116 | MYC_18555785_ChIP-Seq_MESCs_Mouse | 0.74806835 |
| 117 | * LXR_22292898_ChIP-Seq_THP-1_Human | 0.74575252 |
| 118 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 0.74418537 |
| 119 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.73068222 |
| 120 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.72031739 |
| 121 | CHD1_26751641_Chip-Seq_LNCaP_Human | 0.71362694 |
| 122 | RUNX1_27514584_Chip-Seq_MCF-7_Human | 0.70340465 |
| 123 | * ZFP281_27345836_Chip-Seq_ESCs_Mouse | 0.69514136 |
| 124 | RACK7_27058665_Chip-Seq_MCF-7_Human | 0.69462028 |
| 125 | SOX11_23321250_ChIP-ChIP_Z138-A519-JVM2_Human | 0.69041093 |
| 126 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 0.68705216 |
| 127 | KDM5B_21448134_ChIP-Seq_MESCs_Mouse | 0.68551487 |
| 128 | CCND1_20090754_ChIP-ChIP_RETINA_Mouse | 0.68204362 |
| 129 | FLI1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.67881344 |
| 130 | DMRT1_23473982_ChIP-Seq_TESTES_Mouse | 0.66688663 |
| 131 | CREB1_20920259_ChIP-Seq_GC1-SPG_Mouse | 0.65333794 |
| 132 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.65239276 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0003763_abnormal_thymus_physiology | 6.34521983 |
| 2 | MP0002166_altered_tumor_susceptibility | 3.97259005 |
| 3 | MP0005671_abnormal_response_to | 3.78064884 |
| 4 | * MP0000703_abnormal_thymus_morphology | 3.75224124 |
| 5 | MP0000685_abnormal_immune_system | 3.41909344 |
| 6 | MP0002006_tumorigenesis | 3.15778138 |
| 7 | * MP0002398_abnormal_bone_marrow | 2.80787235 |
| 8 | MP0002132_abnormal_respiratory_system | 2.76380333 |
| 9 | MP0004947_skin_inflammation | 2.70416020 |
| 10 | MP0009333_abnormal_splenocyte_physiolog | 2.66344085 |
| 11 | MP0001800_abnormal_humoral_immune | 2.45963278 |
| 12 | * MP0002722_abnormal_immune_system | 2.44314588 |
| 13 | MP0010155_abnormal_intestine_physiology | 2.42123725 |
| 14 | MP0009278_abnormal_bone_marrow | 2.40248954 |
| 15 | * MP0000716_abnormal_immune_system | 2.28912098 |
| 16 | MP0002420_abnormal_adaptive_immunity | 2.28691195 |
| 17 | MP0005409_darkened_coat_color | 2.26984805 |
| 18 | MP0001835_abnormal_antigen_presentation | 2.24629236 |
| 19 | MP0001819_abnormal_immune_cell | 2.24584833 |
| 20 | MP0010094_abnormal_chromosome_stability | 2.24459195 |
| 21 | MP0005387_immune_system_phenotype | 2.23983624 |
| 22 | MP0001790_abnormal_immune_system | 2.23983624 |
| 23 | MP0002405_respiratory_system_inflammati | 2.23768795 |
| 24 | MP0000689_abnormal_spleen_morphology | 2.20293388 |
| 25 | MP0001849_ear_inflammation | 2.15313484 |
| 26 | MP0002723_abnormal_immune_serum | 2.14931476 |
| 27 | MP0005000_abnormal_immune_tolerance | 2.13193392 |
| 28 | MP0004808_abnormal_hematopoietic_stem | 2.11605192 |
| 29 | MP0009785_altered_susceptibility_to | 1.98726441 |
| 30 | MP0003300_gastrointestinal_ulcer | 1.98628097 |
| 31 | MP0002396_abnormal_hematopoietic_system | 1.95850783 |
| 32 | MP0002933_joint_inflammation | 1.93627179 |
| 33 | MP0006082_CNS_inflammation | 1.87202092 |
| 34 | * MP0002429_abnormal_blood_cell | 1.85409820 |
| 35 | MP0002452_abnormal_antigen_presenting | 1.82706142 |
| 36 | MP0005397_hematopoietic_system_phenotyp | 1.73059250 |
| 37 | MP0001545_abnormal_hematopoietic_system | 1.73059250 |
| 38 | MP0010352_gastrointestinal_tract_polyps | 1.63027839 |
| 39 | MP0005025_abnormal_response_to | 1.59530258 |
| 40 | MP0003866_abnormal_defecation | 1.58269616 |
| 41 | MP0001533_abnormal_skeleton_physiology | 1.55341695 |
| 42 | MP0001873_stomach_inflammation | 1.54750625 |
| 43 | MP0005174_abnormal_tail_pigmentation | 1.45514834 |
| 44 | MP0004381_abnormal_hair_follicle | 1.45069617 |
| 45 | MP0008057_abnormal_DNA_replication | 1.35245186 |
| 46 | MP0005076_abnormal_cell_differentiation | 1.33141405 |
| 47 | MP0001845_abnormal_inflammatory_respons | 1.32996283 |
| 48 | MP0003077_abnormal_cell_cycle | 1.29071337 |
| 49 | MP0002095_abnormal_skin_pigmentation | 1.27978617 |
| 50 | MP0003436_decreased_susceptibility_to | 1.25425919 |
| 51 | MP0008961_abnormal_basal_metabolism | 1.25325877 |
| 52 | MP0000490_abnormal_crypts_of | 1.24146584 |
| 53 | MP0003724_increased_susceptibility_to | 1.23732866 |
| 54 | MP0000015_abnormal_ear_pigmentation | 1.21267915 |
| 55 | MP0002019_abnormal_tumor_incidence | 1.21215458 |
| 56 | MP0003693_abnormal_embryo_hatching | 1.19731130 |
| 57 | MP0000858_altered_metastatic_potential | 1.16966814 |
| 58 | MP0005464_abnormal_platelet_physiology | 1.15112195 |
| 59 | MP0002148_abnormal_hypersensitivity_rea | 1.13675476 |
| 60 | MP0004957_abnormal_blastocyst_morpholog | 1.12569145 |
| 61 | MP0002009_preneoplasia | 1.05047060 |
| 62 | MP0001853_heart_inflammation | 1.04918220 |
| 63 | MP0001243_abnormal_dermal_layer | 1.04220925 |
| 64 | MP0003111_abnormal_nucleus_morphology | 1.02700999 |
| 65 | MP0003045_fibrosis | 1.02591213 |
| 66 | MP0004510_myositis | 1.01869221 |
| 67 | MP0002138_abnormal_hepatobiliary_system | 1.01785617 |
| 68 | MP0002419_abnormal_innate_immunity | 1.01762404 |
| 69 | MP0005310_abnormal_salivary_gland | 1.01025739 |
| 70 | MP0008007_abnormal_cellular_replicative | 0.97368067 |
| 71 | MP0003828_pulmonary_edema | 0.96824443 |
| 72 | MP0003303_peritoneal_inflammation | 0.94419196 |
| 73 | MP0003172_abnormal_lysosome_physiology | 0.91226121 |
| 74 | MP0000350_abnormal_cell_proliferation | 0.89898004 |
| 75 | MP0005451_abnormal_body_composition | 0.87846678 |
| 76 | MP0001348_abnormal_lacrimal_gland | 0.87109328 |
| 77 | MP0001986_abnormal_taste_sensitivity | 0.83732351 |
| 78 | MP0002277_abnormal_respiratory_mucosa | 0.82197714 |
| 79 | MP0005075_abnormal_melanosome_morpholog | 0.82138427 |
| 80 | MP0000465_gastrointestinal_hemorrhage | 0.80456331 |
| 81 | MP0008260_abnormal_autophagy | 0.79138280 |
| 82 | MP0001730_embryonic_growth_arrest | 0.78153654 |
| 83 | MP0001663_abnormal_digestive_system | 0.77767239 |
| 84 | MP0002998_abnormal_bone_remodeling | 0.76623659 |
| 85 | MP0008770_decreased_survivor_rate | 0.75050972 |
| 86 | MP0002075_abnormal_coat/hair_pigmentati | 0.74759101 |
| 87 | MP0003191_abnormal_cellular_cholesterol | 0.73885212 |
| 88 | MP0008877_abnormal_DNA_methylation | 0.73767026 |
| 89 | MP0000383_abnormal_hair_follicle | 0.73730622 |
| 90 | MP0001879_abnormal_lymphatic_vessel | 0.72139770 |
| 91 | MP0001851_eye_inflammation | 0.71962062 |
| 92 | MP0003448_altered_tumor_morphology | 0.70850819 |
| 93 | MP0009764_decreased_sensitivity_to | 0.70298904 |
| 94 | MP0005023_abnormal_wound_healing | 0.68841945 |
| 95 | MP0002163_abnormal_gland_morphology | 0.67472659 |
| 96 | MP0004185_abnormal_adipocyte_glucose | 0.67187447 |
| 97 | MP0008058_abnormal_DNA_repair | 0.65967628 |
| 98 | MP0000477_abnormal_intestine_morphology | 0.65771780 |
| 99 | MP0009115_abnormal_fat_cell | 0.65533283 |
| 100 | MP0009763_increased_sensitivity_to | 0.64438003 |
| 101 | MP0001191_abnormal_skin_condition | 0.64373198 |
| 102 | MP0004883_abnormal_blood_vessel | 0.63748215 |
| 103 | MP0003959_abnormal_lean_body | 0.62211082 |
| 104 | MP0000609_abnormal_liver_physiology | 0.62020498 |
| 105 | MP0002086_abnormal_extraembryonic_tissu | 0.61912068 |
| 106 | MP0002928_abnormal_bile_duct | 0.60639830 |
| 107 | MP0004130_abnormal_muscle_cell | 0.58605832 |
| 108 | MP0000313_abnormal_cell_death | 0.58394412 |
| 109 | MP0003787_abnormal_imprinting | 0.57894164 |
| 110 | MP0002088_abnormal_embryonic_growth/wei | 0.56557724 |
| 111 | MP0002970_abnormal_white_adipose | 0.56021844 |
| 112 | MP0000367_abnormal_coat/_hair | 0.55901727 |
| 113 | MP0003984_embryonic_growth_retardation | 0.54716618 |
| 114 | MP0001216_abnormal_epidermal_layer | 0.54189632 |
| 115 | MP0009765_abnormal_xenobiotic_induced | 0.53679785 |
| 116 | MP0008469_abnormal_protein_level | 0.51608633 |
| 117 | MP0010307_abnormal_tumor_latency | 0.51460772 |
| 118 | MP0004197_abnormal_fetal_growth/weight/ | 0.51046219 |
| 119 | MP0002080_prenatal_lethality | 0.50685036 |
| 120 | MP0002693_abnormal_pancreas_physiology | 0.50422706 |
| 121 | MP0003183_abnormal_peptide_metabolism | 0.49511164 |
| 122 | MP0000249_abnormal_blood_vessel | 0.47025931 |
| 123 | MP0005390_skeleton_phenotype | 0.46779865 |
| 124 | MP0003795_abnormal_bone_structure | 0.44027833 |
| 125 | MP0001919_abnormal_reproductive_system | 0.43782915 |
| 126 | MP0003252_abnormal_bile_duct | 0.41642136 |
| 127 | MP0003646_muscle_fatigue | 0.39954470 |
| 128 | MP0002083_premature_death | 0.37705360 |
| 129 | MP0003279_aneurysm | 0.36957593 |
| 130 | MP0008569_lethality_at_weaning | 0.36484345 |
| 131 | MP0005381_digestive/alimentary_phenotyp | 0.35975748 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | B lymphocytopenia (HP:0010976) | 8.66091685 |
| 2 | Abnormality of B cell number (HP:0010975) | 8.66091685 |
| 3 | Severe combined immunodeficiency (HP:0004430) | 8.59302765 |
| 4 | Combined immunodeficiency (HP:0005387) | 7.77155811 |
| 5 | Panhypogammaglobulinemia (HP:0003139) | 7.68909548 |
| 6 | Hypoplasia of the thymus (HP:0000778) | 7.67083414 |
| 7 | Thyroiditis (HP:0100646) | 7.44131998 |
| 8 | Eosinophilia (HP:0001880) | 6.96000867 |
| 9 | Recurrent viral infections (HP:0004429) | 6.22199554 |
| 10 | Abnormality of T cells (HP:0002843) | 5.82342078 |
| 11 | Granulocytopenia (HP:0001913) | 5.75606677 |
| 12 | Abnormality of eosinophils (HP:0001879) | 5.64709226 |
| 13 | Hypoproteinemia (HP:0003075) | 4.85994165 |
| 14 | Recurrent fungal infections (HP:0002841) | 4.72310754 |
| 15 | IgG deficiency (HP:0004315) | 4.66207420 |
| 16 | Leukocytosis (HP:0001974) | 4.23955176 |
| 17 | Abnormality of the fingertips (HP:0001211) | 3.93320040 |
| 18 | Recurrent bacterial skin infections (HP:0005406) | 3.82208695 |
| 19 | Recurrent abscess formation (HP:0002722) | 3.80472107 |
| 20 | Retrobulbar optic neuritis (HP:0100654) | 3.76357568 |
| 21 | Optic neuritis (HP:0100653) | 3.76357568 |
| 22 | Orchitis (HP:0100796) | 3.67347253 |
| 23 | Mediastinal lymphadenopathy (HP:0100721) | 3.37651986 |
| 24 | Vasculitis (HP:0002633) | 3.32132506 |
| 25 | Elevated erythrocyte sedimentation rate (HP:0003565) | 3.29148073 |
| 26 | Erythroderma (HP:0001019) | 3.22047464 |
| 27 | Papilledema (HP:0001085) | 3.14901358 |
| 28 | Abnormality of macrophages (HP:0004311) | 3.13893548 |
| 29 | Aplasia/Hypoplasia of the thymus (HP:0010515) | 2.97821303 |
| 30 | Obstructive lung disease (HP:0006536) | 2.92280969 |
| 31 | Chronic obstructive pulmonary disease (HP:0006510) | 2.92280969 |
| 32 | Recurrent skin infections (HP:0001581) | 2.91917771 |
| 33 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 2.82803238 |
| 34 | Stomatitis (HP:0010280) | 2.82780645 |
| 35 | Pustule (HP:0200039) | 2.80473519 |
| 36 | Pulmonary infiltrates (HP:0002113) | 2.74954336 |
| 37 | Colitis (HP:0002583) | 2.71805714 |
| 38 | Keratoconjunctivitis sicca (HP:0001097) | 2.68480431 |
| 39 | Basal cell carcinoma (HP:0002671) | 2.65123458 |
| 40 | Agammaglobulinemia (HP:0004432) | 2.61252159 |
| 41 | Chest pain (HP:0100749) | 2.57244420 |
| 42 | Nasal polyposis (HP:0100582) | 2.56522296 |
| 43 | Keratoconjunctivitis (HP:0001096) | 2.55906605 |
| 44 | Lymphoma (HP:0002665) | 2.55234341 |
| 45 | Chronic otitis media (HP:0000389) | 2.51865192 |
| 46 | Recurrent gram-negative bacterial infections (HP:0005420) | 2.51506673 |
| 47 | Recurrent bronchitis (HP:0002837) | 2.51029856 |
| 48 | Autoimmune thrombocytopenia (HP:0001973) | 2.50137653 |
| 49 | Abnormality of the thymus (HP:0000777) | 2.49109973 |
| 50 | Slow saccadic eye movements (HP:0000514) | 2.46298194 |
| 51 | Recurrent cutaneous fungal infections (HP:0011370) | 2.46076508 |
| 52 | Chronic mucocutaneous candidiasis (HP:0002728) | 2.46076508 |
| 53 | Gastrointestinal stroma tumor (HP:0100723) | 2.42187676 |
| 54 | Meningitis (HP:0001287) | 2.41123530 |
| 55 | IgM deficiency (HP:0002850) | 2.39863396 |
| 56 | Hypochromic microcytic anemia (HP:0004840) | 2.34725096 |
| 57 | Cellular immunodeficiency (HP:0005374) | 2.33807614 |
| 58 | Parkinsonism with favorable response to dopaminergic medication (HP:0002548) | 2.31219052 |
| 59 | Autoimmune hemolytic anemia (HP:0001890) | 2.30833856 |
| 60 | Pulmonary embolism (HP:0002204) | 2.30788119 |
| 61 | Bicuspid aortic valve (HP:0001647) | 2.28671590 |
| 62 | Cellulitis (HP:0100658) | 2.26938530 |
| 63 | Abnormality of the columella (HP:0009929) | 2.23982804 |
| 64 | Joint swelling (HP:0001386) | 2.18826061 |
| 65 | Volvulus (HP:0002580) | 2.17860288 |
| 66 | Stomach cancer (HP:0012126) | 2.17658399 |
| 67 | Gingivitis (HP:0000230) | 2.17623388 |
| 68 | Microcytic anemia (HP:0001935) | 2.16959552 |
| 69 | Papilloma (HP:0012740) | 2.16945070 |
| 70 | Verrucae (HP:0200043) | 2.16945070 |
| 71 | Abnormality of the nasal mucosa (HP:0000433) | 2.08973869 |
| 72 | Anorexia (HP:0002039) | 2.07217557 |
| 73 | Urticaria (HP:0001025) | 2.06736201 |
| 74 | Lymphopenia (HP:0001888) | 2.05088034 |
| 75 | Increased IgM level (HP:0003496) | 2.03671600 |
| 76 | Abnormality of cells of the lymphoid lineage (HP:0012140) | 2.03167225 |
| 77 | Spontaneous hematomas (HP:0007420) | 2.01147598 |
| 78 | T lymphocytopenia (HP:0005403) | 10.8269726 |
| 79 | Abnormality of T cell number (HP:0011839) | 10.2630650 |
| 80 | Acute hepatic failure (HP:0006554) | 1.93454994 |
| 81 | Arterial thrombosis (HP:0004420) | 1.92919695 |
| 82 | Hematochezia (HP:0002573) | 1.91020581 |
| 83 | Viral hepatitis (HP:0006562) | 1.90542172 |
| 84 | Abnormality of T cell physiology (HP:0011840) | 1.89953042 |
| 85 | Deep philtrum (HP:0002002) | 1.87314019 |
| 86 | Recurrent sinusitis (HP:0011108) | 1.86300347 |
| 87 | Abnormality of the pleura (HP:0002103) | 1.83572724 |
| 88 | Gangrene (HP:0100758) | 1.82241617 |
| 89 | Teleangiectasia of the skin (HP:0100585) | 1.82064529 |
| 90 | Chronic diarrhea (HP:0002028) | 1.81780399 |
| 91 | Subacute progressive viral hepatitis (HP:0006572) | 1.78211218 |
| 92 | Osteomyelitis (HP:0002754) | 1.77440807 |
| 93 | Broad face (HP:0000283) | 1.76281144 |
| 94 | Gingival bleeding (HP:0000225) | 1.75296754 |
| 95 | Myositis (HP:0100614) | 1.73054373 |
| 96 | Hyperacusis (HP:0010780) | 1.71033558 |
| 97 | Increased IgE level (HP:0003212) | 1.67604924 |
| 98 | Encephalitis (HP:0002383) | 1.66355507 |
| 99 | Broad palm (HP:0001169) | 1.65636238 |
| 100 | Sparse lateral eyebrow (HP:0005338) | 1.65040645 |
| 101 | Abnormal platelet volume (HP:0011876) | 1.61926472 |
| 102 | Bronchiectasis (HP:0002110) | 1.58958821 |
| 103 | Eczematoid dermatitis (HP:0000976) | 1.58634450 |
| 104 | Cutis marmorata (HP:0000965) | 1.56214213 |
| 105 | Sepsis (HP:0100806) | 1.55134497 |
| 106 | Gastrointestinal inflammation (HP:0004386) | 1.53729018 |
| 107 | Acute lymphatic leukemia (HP:0006721) | 1.51328607 |
| 108 | Inflammation of the large intestine (HP:0002037) | 1.47023601 |
| 109 | Prominent nose (HP:0000448) | 1.46691962 |
| 110 | Dislocated radial head (HP:0003083) | 1.45810573 |
| 111 | Long eyelashes (HP:0000527) | 1.45766778 |
| 112 | Heterotopia (HP:0002282) | 1.44373284 |
| 113 | Increased nuchal translucency (HP:0010880) | 1.43566220 |
| 114 | Trigonocephaly (HP:0000243) | 1.42710341 |
| 115 | Abnormality of oral frenula (HP:0000190) | 1.41373193 |
| 116 | Recurrent otitis media (HP:0000403) | 1.40493354 |
| 117 | Proximal placement of thumb (HP:0009623) | 1.40434910 |
| 118 | Increased density of long bones (HP:0006392) | 1.39825242 |
| 119 | Hypergammaglobulinemia (HP:0010702) | 1.37521920 |
| 120 | Persistence of primary teeth (HP:0006335) | 1.37463571 |
| 121 | Prolonged bleeding time (HP:0003010) | 1.36085250 |
| 122 | Bronchitis (HP:0012387) | 1.36056758 |
| 123 | Abnormality of the radial head (HP:0003995) | 1.34585655 |
| 124 | Ureteral stenosis (HP:0000071) | 1.34490303 |
| 125 | Poikiloderma (HP:0001029) | 1.31010227 |
| 126 | Hemoptysis (HP:0002105) | 1.29728056 |
| 127 | Abnormal foot bone ossification (HP:0010675) | 1.29518443 |
| 128 | Gastrointestinal infarctions (HP:0005244) | 1.28468838 |
| 129 | Deviation of the thumb (HP:0009603) | 1.27821715 |
| 130 | Hepatitis (HP:0012115) | 1.27750955 |
| 131 | Depressed nasal tip (HP:0000437) | 1.26860464 |
| 132 | Increased mean platelet volume (HP:0011877) | 1.26857880 |
| 133 | Aortic aneurysm (HP:0004942) | 1.26524080 |
| 134 | Seborrheic dermatitis (HP:0001051) | 1.26184846 |
| 135 | Mitral regurgitation (HP:0001653) | 1.26139237 |
| 136 | IgA deficiency (HP:0002720) | 1.25333068 |
| 137 | Amaurosis fugax (HP:0100576) | 1.25207843 |
| 138 | Macroorchidism (HP:0000053) | 1.25007110 |
| 139 | Acute myeloid leukemia (HP:0004808) | 1.23596614 |
| 140 | Hypochromic anemia (HP:0001931) | 1.22549275 |
| 141 | Ureteral obstruction (HP:0006000) | 1.20594357 |
| 142 | Skin tags (HP:0010609) | 1.19381131 |
| 143 | Epistaxis (HP:0000421) | 1.19272348 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | TXK | 5.89334033 |
| 2 | MAP4K1 | 5.05145797 |
| 3 | PRPF4B | 3.21015175 |
| 4 | ITK | 3.12157206 |
| 5 | ZAP70 | 3.08673154 |
| 6 | GRK6 | 2.92803492 |
| 7 | STK10 | 2.68999735 |
| 8 | EEF2K | 2.52435366 |
| 9 | RIPK4 | 2.52136351 |
| 10 | CDK12 | 2.44673626 |
| 11 | MAP3K10 | 2.43866784 |
| 12 | FGFR4 | 2.40967952 |
| 13 | NLK | 2.30724163 |
| 14 | TAOK3 | 2.28077675 |
| 15 | PKN2 | 2.18982888 |
| 16 | JAK3 | 2.13396691 |
| 17 | MST4 | 2.01987592 |
| 18 | TYK2 | 1.96203039 |
| 19 | FGFR3 | 1.91256292 |
| 20 | PDGFRB | 1.79287611 |
| 21 | LCK | 1.72114985 |
| 22 | CSK | 1.67588736 |
| 23 | SYK | 1.67566630 |
| 24 | IRAK4 | 1.61534619 |
| 25 | MAP3K7 | 1.54222677 |
| 26 | CAMKK1 | 1.51427117 |
| 27 | YES1 | 1.47164708 |
| 28 | HCK | 1.45801703 |
| 29 | BLK | 1.43909269 |
| 30 | MAPK7 | 1.42603904 |
| 31 | IKBKE | 1.39744778 |
| 32 | SMG1 | 1.29740163 |
| 33 | FGFR2 | 1.29551584 |
| 34 | CDC7 | 1.27955660 |
| 35 | PRKCH | 1.25941834 |
| 36 | PRKCQ | 1.25575763 |
| 37 | TYRO3 | 1.22352083 |
| 38 | LRRK2 | 1.21029591 |
| 39 | MAP2K3 | 1.17165891 |
| 40 | TRIB3 | 1.16919661 |
| 41 | BRD4 | 1.15476493 |
| 42 | ERN1 | 1.13023581 |
| 43 | MAP2K2 | 1.12606716 |
| 44 | BTK | 1.11634146 |
| 45 | TEC | 1.09765409 |
| 46 | SIK2 | 1.09610410 |
| 47 | RPS6KB2 | 1.03421287 |
| 48 | CLK1 | 1.03322920 |
| 49 | JAK1 | 1.03322182 |
| 50 | PTK6 | 0.98379283 |
| 51 | SIK1 | 0.95471904 |
| 52 | CDK4 | 0.94282179 |
| 53 | MARK2 | 0.93798092 |
| 54 | STK4 | 0.90999091 |
| 55 | NEK2 | 0.88712879 |
| 56 | MAP3K14 | 0.88352724 |
| 57 | JAK2 | 0.86695091 |
| 58 | NME2 | 0.86012373 |
| 59 | TESK2 | 0.85940238 |
| 60 | RPS6KA4 | 0.85376636 |
| 61 | CDK6 | 0.85059797 |
| 62 | EPHB1 | 0.82891854 |
| 63 | MAP3K13 | 0.82501725 |
| 64 | CSNK1A1L | 0.82114081 |
| 65 | PIM1 | 0.82034502 |
| 66 | CDC42BPA | 0.80891694 |
| 67 | HIPK2 | 0.80193091 |
| 68 | STK38 | 0.80022342 |
| 69 | MARK3 | 0.76021760 |
| 70 | MAPK12 | 0.75375789 |
| 71 | MAP3K3 | 0.75172689 |
| 72 | MAP3K1 | 0.72850058 |
| 73 | ALK | 0.72088713 |
| 74 | MELK | 0.70648972 |
| 75 | KSR2 | 0.70261084 |
| 76 | FLT3 | 0.65641149 |
| 77 | PASK | 0.63234613 |
| 78 | TNK2 | 0.62710643 |
| 79 | CSNK1G3 | 0.61759991 |
| 80 | MAPK4 | 0.60404467 |
| 81 | FGFR1 | 0.59145195 |
| 82 | INSR | 0.57193918 |
| 83 | CSNK1G1 | 0.56240681 |
| 84 | CSF1R | 0.55435184 |
| 85 | ICK | 0.53947667 |
| 86 | CDK9 | 0.53830134 |
| 87 | TBK1 | 0.52249236 |
| 88 | FGR | 0.52134009 |
| 89 | PRKD2 | 0.51928365 |
| 90 | STK11 | 0.50282991 |
| 91 | MAP3K8 | 0.49287682 |
| 92 | KDR | 0.47816255 |
| 93 | CHEK1 | 0.47274247 |
| 94 | TSSK6 | 0.47263801 |
| 95 | CHUK | 0.47120765 |
| 96 | FYN | 0.45164258 |
| 97 | IRAK1 | 0.44834014 |
| 98 | MAP3K11 | 0.44731065 |
| 99 | ATR | 0.43944532 |
| 100 | SGK3 | 0.43104431 |
| 101 | NTRK2 | 0.41999323 |
| 102 | CSNK1G2 | 0.41754510 |
| 103 | RET | 0.41689419 |
| 104 | WNK1 | 0.38933642 |
| 105 | PDPK1 | 0.38444109 |
| 106 | TAOK1 | 0.38009957 |
| 107 | MAPK3 | 0.37275974 |
| 108 | FES | 0.35703087 |
| 109 | PDK1 | 0.35645870 |
| 110 | MAPK11 | 0.35182512 |
| 111 | ATM | 0.34917075 |
| 112 | RPS6KL1 | 0.34596888 |
| 113 | RPS6KC1 | 0.34596888 |
| 114 | TGFBR1 | 0.34550835 |
| 115 | NEK6 | 0.33918651 |
| 116 | LYN | 0.33907741 |
| 117 | MAP3K2 | 0.33801715 |
| 118 | IKBKB | 0.33605581 |
| 119 | RPS6KA6 | 0.33066085 |
| 120 | LATS1 | 0.32060738 |
| 121 | SIK3 | 0.31899804 |
| 122 | PDGFRA | 0.31893171 |
| 123 | PIK3CG | 0.30885905 |
| 124 | MTOR | 0.30784629 |
| 125 | CDK2 | 0.30619299 |
| 126 | DYRK1B | 0.29627871 |
| 127 | KIT | 0.29447153 |
| 128 | MAPK9 | 0.29006044 |
| 129 | MKNK2 | 0.28827456 |
| 130 | CAMK4 | 0.28687344 |
| 131 | UHMK1 | 0.28623038 |
| 132 | EPHA3 | 0.28509514 |
| 133 | CAMKK2 | 0.27682988 |
| 134 | CSNK1D | 0.26508219 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Primary immunodeficiency_Homo sapiens_hsa05340 | 7.53966460 |
| 2 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 4.67092566 |
| 3 | Non-homologous end-joining_Homo sapiens_hsa03450 | 3.27540326 |
| 4 | Antigen processing and presentation_Homo sapiens_hsa04612 | 2.63048764 |
| 5 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 2.54692057 |
| 6 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 2.43421626 |
| 7 | Measles_Homo sapiens_hsa05162 | 2.27833268 |
| 8 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 2.12748851 |
| 9 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 2.09188717 |
| 10 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.88245639 |
| 11 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 1.64838711 |
| 12 | Osteoclast differentiation_Homo sapiens_hsa04380 | 1.61298487 |
| 13 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 1.52381856 |
| 14 | HTLV-I infection_Homo sapiens_hsa05166 | 1.47433894 |
| 15 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 1.46994193 |
| 16 | Spliceosome_Homo sapiens_hsa03040 | 1.39827643 |
| 17 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.39135594 |
| 18 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.37638581 |
| 19 | Viral myocarditis_Homo sapiens_hsa05416 | 1.37395272 |
| 20 | Hepatitis B_Homo sapiens_hsa05161 | 1.33048330 |
| 21 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 1.29228312 |
| 22 | * Acute myeloid leukemia_Homo sapiens_hsa05221 | 1.26312706 |
| 23 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.25637549 |
| 24 | DNA replication_Homo sapiens_hsa03030 | 1.19186164 |
| 25 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.18841210 |
| 26 | Tuberculosis_Homo sapiens_hsa05152 | 1.18460692 |
| 27 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.15353082 |
| 28 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.14395811 |
| 29 | mRNA surveillance pathway_Homo sapiens_hsa03015 | 1.10699004 |
| 30 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 1.08158440 |
| 31 | Leishmaniasis_Homo sapiens_hsa05140 | 1.07920789 |
| 32 | Graft-versus-host disease_Homo sapiens_hsa05332 | 1.07567788 |
| 33 | FoxO signaling pathway_Homo sapiens_hsa04068 | 1.06652380 |
| 34 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 1.06320582 |
| 35 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.06247824 |
| 36 | Allograft rejection_Homo sapiens_hsa05330 | 1.05550390 |
| 37 | Pancreatic cancer_Homo sapiens_hsa05212 | 1.05065318 |
| 38 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 1.04883008 |
| 39 | Mismatch repair_Homo sapiens_hsa03430 | 1.04085444 |
| 40 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 1.02757319 |
| 41 | * Colorectal cancer_Homo sapiens_hsa05210 | 1.01937401 |
| 42 | Lysine degradation_Homo sapiens_hsa00310 | 0.98979919 |
| 43 | Malaria_Homo sapiens_hsa05144 | 0.98246487 |
| 44 | Cell cycle_Homo sapiens_hsa04110 | 0.98062328 |
| 45 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.96043713 |
| 46 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.95805021 |
| 47 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.93263973 |
| 48 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 0.86947528 |
| 49 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.83879518 |
| 50 | Platelet activation_Homo sapiens_hsa04611 | 0.82999858 |
| 51 | Ribosome_Homo sapiens_hsa03010 | 0.82933765 |
| 52 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.82693164 |
| 53 | Influenza A_Homo sapiens_hsa05164 | 0.82308338 |
| 54 | Base excision repair_Homo sapiens_hsa03410 | 0.81161251 |
| 55 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.79808781 |
| 56 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.77961224 |
| 57 | RNA degradation_Homo sapiens_hsa03018 | 0.77141173 |
| 58 | Asthma_Homo sapiens_hsa05310 | 0.77135431 |
| 59 | Apoptosis_Homo sapiens_hsa04210 | 0.75140117 |
| 60 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.74249408 |
| 61 | Shigellosis_Homo sapiens_hsa05131 | 0.73604106 |
| 62 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 0.72701800 |
| 63 | Other glycan degradation_Homo sapiens_hsa00511 | 0.72604838 |
| 64 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.72281978 |
| 65 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.72017983 |
| 66 | RNA transport_Homo sapiens_hsa03013 | 0.71335427 |
| 67 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.71147551 |
| 68 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 0.70989534 |
| 69 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.69683130 |
| 70 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.68023811 |
| 71 | Glioma_Homo sapiens_hsa05214 | 0.67986935 |
| 72 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.67936094 |
| 73 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.66636008 |
| 74 | p53 signaling pathway_Homo sapiens_hsa04115 | 0.65159670 |
| 75 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.64062943 |
| 76 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.63645464 |
| 77 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.62717892 |
| 78 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.61634662 |
| 79 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.60388906 |
| 80 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.58867486 |
| 81 | * Prostate cancer_Homo sapiens_hsa05215 | 0.58593123 |
| 82 | * Endometrial cancer_Homo sapiens_hsa05213 | 0.56437541 |
| 83 | Hepatitis C_Homo sapiens_hsa05160 | 0.56393976 |
| 84 | Long-term potentiation_Homo sapiens_hsa04720 | 0.55783887 |
| 85 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.55783458 |
| 86 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.54310745 |
| 87 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 0.50130336 |
| 88 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 0.49827412 |
| 89 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.49607251 |
| 90 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.49316341 |
| 91 | * Pathways in cancer_Homo sapiens_hsa05200 | 0.48556466 |
| 92 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.48244093 |
| 93 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.47216686 |
| 94 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.47115593 |
| 95 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.46735288 |
| 96 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.46325644 |
| 97 | Insulin resistance_Homo sapiens_hsa04931 | 0.45453453 |
| 98 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.44032557 |
| 99 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.43779271 |
| 100 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 0.43604977 |
| 101 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.43357923 |
| 102 | Progesterone-mediated oocyte maturation_Homo sapiens_hsa04914 | 0.42774358 |
| 103 | Nucleotide excision repair_Homo sapiens_hsa03420 | 0.42496264 |
| 104 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.41200239 |
| 105 | Endocytosis_Homo sapiens_hsa04144 | 0.39128864 |
| 106 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.38762891 |
| 107 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.38571319 |
| 108 | Ubiquitin mediated proteolysis_Homo sapiens_hsa04120 | 0.37630680 |
| 109 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.36491342 |
| 110 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.34818288 |
| 111 | Circadian rhythm_Homo sapiens_hsa04710 | 0.34699156 |
| 112 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.34545877 |
| 113 | * Adherens junction_Homo sapiens_hsa04520 | 0.33874343 |
| 114 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.32864549 |
| 115 | * Thyroid cancer_Homo sapiens_hsa05216 | 0.32846361 |
| 116 | Pertussis_Homo sapiens_hsa05133 | 0.32431865 |
| 117 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.32130178 |
| 118 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.31645277 |
| 119 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.31168467 |
| 120 | Cholinergic synapse_Homo sapiens_hsa04725 | 0.30996595 |
| 121 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.30383155 |
| 122 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.28115118 |
| 123 | Legionellosis_Homo sapiens_hsa05134 | 0.27313887 |
| 124 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.26910054 |

